Form 4: Twist Bioscience SVP of Human Resources Sells Shares to Cover Tax Obligations

Paula Green, SVP of Human Resources at Twist Bioscience, sold 160 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Paula Green, the Senior Vice President of Human Resources at Twist Bioscience, sold 160 shares of the company's common stock on January 3, 2025.
• The sale was executed at a price of $45.5911 per share.
• This transaction was not a discretionary trade but rather a 'sell to cover' transaction mandated by the company to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Ms. Green directly owns 133,273 shares of Twist Bioscience common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither positive nor negative for the company's outlook, but it is a normal part of operations.

Industry Context

This is a routine transaction related to executive compensation and is common for companies that offer equity-based compensation. It does not indicate any change in the company's performance or outlook.

Comparison to Industry Standards

• Similar 'sell to cover' transactions are common among publicly traded companies, especially in the technology and biotech sectors where stock options and restricted stock units are frequently used as part of compensation packages.
• Companies like Illumina, Regeneron, and BioMarin also have executives who regularly file Form 4s for similar transactions related to stock vesting and tax obligations.
• The number of shares sold and the price are specific to the individual's vesting schedule and the company's stock price at the time of vesting, making direct comparisons difficult without detailed knowledge of the specific compensation plans.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• The sale does not affect the company's operations or financial health.

Key Dates

Keywords

Twist Bioscience, stock sale, insider trading, Paula Green, tax obligations, restricted stock units, equity compensation, Form 4